Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody response comparison of intradermal versus intramuscular botulinum toxin type A injections
TCTR20211215001Phase 4Completed
- Sponsor
- Siriraj Hospital
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in Rhytidosis facialis, masseter hypertrophy, sponsored by Siriraj Hospital. Started Sep 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Rhytidosis facialismasseter hypertrophy
Beyond the preview
Go deeper on TCTR20211215001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211215001.